CVRx, Inc.

CVRX ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Operating Activities
Net Income $-53.3M $-60.0M $-41.2M $-41.4M $-43.1M $-14.1M
Depreciation & Amortization
Depreciation $756.0K $619.0K $522.0K $412.0K $168.0K $75.0K
Amortization
Stock-Based Compensation $11.1M $19.1M $6.3M $3.9M $1.9M $132.0K
Net Cash from Operating Activities $-40.2M $-39.1M $-39.0M $-42.7M $-27.7M $-16.1M
Investing Activities
Capital Expenditures $580.0K $1.4M $591.0K $685.0K $1.2M $311.0K
Business Acquisitions
Net Cash from Investing Activities $-580.0K $-1.4M $-591.0K $-685.0K $-1.2M $-311.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $10.5M $55.9M $24.0M $7.5M $111.9M $49.8M
Net Change in Cash $-30.2M $15.4M $-15.6M $-35.9M $83.0M $33.4M
Free Cash Flow $-40.8M $-40.5M $-39.6M $-43.4M $-28.9M $-16.4M